ReviewJAMA oncology2020

Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma: A Review.

Frederick L Locke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.